Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CRSP | CRISPR Therapeutics AG | Director | $55 M | May 30, 2024 | ||
NKTX | Nkarta, Inc. | Director | $4.52 M | +$20 M | Jun 13, 2024 | |
DSGN | Design Therapeutics, Inc. | Director, 10%+ Owner | Jun 13, 2024 | |||
TPTX | Turning Point Therapeutics, Inc. | Director | Aug 17, 2022 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|